Qube Research & Technologies (QRT)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
5,800
+3,700
+176% +$797K ﹤0.01% 2405
2025
Q4
$432K Buy
2,100
+200
+11% +$37.6K ﹤0.01% 2845
2025
Q3
$298K Buy
+1,900
New +$293K ﹤0.01% 2850
2023
Q4
Sell
-200
Closed -$17.4K 4364
2023
Q3
$17.4K Buy
+200
New +$18.1K ﹤0.01% 3187

Other funds holding CAH

Qube Research & Technologies (QRT)'s CAH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Cardinal Health (CAH) stake by 3.3% in Q1 2026, selling an estimated $7.5M and leaving 1,012,309 shares worth $214M. The position accounts for 0.24% of the portfolio, ranked #85.

Qube Research & Technologies (QRT) first reported a position in CAH in Q2 2018 and has held it in 20 quarters since. The position peaked at $239M in Q2 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,012,309 shares of Cardinal Health worth $214M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 34,826 Cardinal Health shares in Q1 2026, an estimated $7.5M.
  • Cardinal Health made up 0.24% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #85 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cardinal Health in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Cardinal Health position peaked at $239M in Q2 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.